Developing a novel therapeutic for the rare disease Creatine Transporter Deficiency, an inborn error of metabolism

Sectors
Healthcare
Life Sciences
First Invested
2014
Early
Company Status
Acquired by NewLink Genetics
Associated Team
Edward Mathers